4-(2-(2-Hydroxyethoxy)ethyl)morpholine
Grundinformationen
- CAS
3603-45-0- Standard-SMILES
OCCOCCN1CCOCC1- InChIKey
BLIMWOGCOCPQEU-UHFFFAOYSA-N- Summenformel
- C8H17NO3
- Durchschnittliche Molmasse
- 175,23 g/mol
- Monoisotopische Masse
- 175,1208434
Namen und Bezeichner
- Bevorzugter Name
- 4-(2-(2-Hydroxyethoxy)ethyl)morpholine
- IUPAC
- 2-(2-morpholin-4-ylethoxy)ethanol
- Englischer Name
- 4-[2-(2-Hydroxyethoxy)ethyl]Morpholine
- Summenformel
- C8H17NO3
- Molmasse
- 175.23
Namen und Synonyme
4-[2-(2-Hydroxyethoxy)ethyl]morpholine4-(2-(2-Hydroxyethoxy)ethyl)morpholineRefChem:511615893-309-23603-45-02-(2-morpholinoethoxy)ethanol2-(2-morpholin-4-ylethoxy)ethanolMFCD010958222-[2-(morpholin-4-yl)ethoxy]ethan-1-ol2-(2-morpholinoethoxy)ethan-1-ol2-(2-morpholin-4-ylethoxy)ethan-1-olEthanol, 2-[2-(4-morpholinyl)ethoxy]-
Weitere Namen anzeigen
2-[2-(4-Morpholinyl)ethoxy]ethanol
SCHEMBL503668SCHEMBL1467966DTXSID40332519BLIMWOGCOCPQEU-UHFFFAOYSA-N2-(2-morpholin-4 ylethoxy)ethanolALBB-031758DAA60345AC1380
Datenbank-Bezeichner
- CAS
3603-45-0- PubChem CID
- 458464
- DTXSID
DTXSID40332519- EC Number
- 893-309-2
- Nikkaji
- J3.410.314C
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- -0,9
- Polarare Oberfläche (TPSA)
- 41,9 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 4
- Frei drehbare Bindungen
- 5
- Schwere Atome
- 12
- Formalladung
- 0
- Komplexität
- 104
Physikochemische Eigenschaften
- Siedepunkt
- 106 · 106-108 °C(Press: 3 Torr)
- Dichte
- 1.074 · 1.074±0.06 g/cm3(Predicted)
- storage temp.
- 2 · 2-8°C
- pka
- 14.4 · 14.40±0.10(Predicted)
Sicherheit und Regulatorisches
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
GHS-Klassifizierung
GHS Classification
Danger
H302 (50%): Harmful if swallowed [Warning Acute toxicity, oral]；H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]；H318 (50%): Causes serious eye damage [Danger Serious eye damage/eye irritation]；H319 (50%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]；H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P305+P354+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.；Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Gefahrenhinweise
Hazard Classes and CategoriesAcute Tox. 4 (50%)；Skin Irrit. 2 (100%)；Eye Dam. 1 (50%)；STOT SE 3 (100%)
Sicherheitsdaten
- Alarmwort
- Warnung
- Gefahrenhinweise
- Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code H302
Chemie und Industrie
Anwendungen
Verwenden4-[2-(2-Hydroxyethoxy)ethyl]morpholine is used in preparation of Triazolotriazine derivatives as A2A receptor antagonists.
Anbieter42 Anbieter
上海凌富药物研究有限公司+86(21)5895 0110 19945755304 · [email protected]
上海麦克林生化科技股份有限公司021-50706066 15221275939 · [email protected]
韶远科技（上海）有限公司4000665055 · [email protected]
Sinco Pharmachem (ShenZhen) R&D Co., Ltd.+86-18603013401 · [email protected]
毕佳索（上海毕得医药科技股份有限公司）400-6005915 · [email protected]
北京索莱宝科技有限公司010-50973130 17801761073 · [email protected]
安耐吉化学&3A（安徽泽升科技有限公司）021-58432009 400-005-6266 · [email protected]
陕西纬宇新材料有限公司13772052144 13772052144 · [email protected]
上海辅欣医药科技有限公司021-50872116 13391048226 · [email protected]
泰州市鑫泓川新材料有限公司18651157028 18651157028 · [email protected]
宝鸡缔都医药化工有限公司029-81145305 17791533577 · [email protected]
Shanghai Scibiotron Pharmaceutical Co., Ltd+86-16621589600 · [email protected]
Zugehörige Reaktionen
13
Notizen zur Verbindung
Wird geladen…